Luís Más

8.1k total citations
59 papers, 1.0k citations indexed

About

Luís Más is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Luís Más has authored 59 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Luís Más's work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Luís Más is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Luís Más collaborates with scholars based in Peru, United States and Mexico. Luís Más's co-authors include Carlos Vallejos, Joseph A. Pinto, Rossana Ruiz, Luis E. Raez, Jhajaira M. Araujo, Henry Gómez, Carole Tarpin, Lini Pandite, Wichai Termrungruanglert and Ana Oaknin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Luís Más

54 papers receiving 994 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luís Más Peru 13 529 469 258 194 114 59 1.0k
Aránzazu Manzano Spain 16 571 1.1× 308 0.7× 240 0.9× 200 1.0× 131 1.1× 58 1.1k
Catherine Shannon Australia 20 704 1.3× 286 0.6× 148 0.6× 285 1.5× 141 1.2× 48 1.2k
Susan Schumer United States 9 422 0.8× 338 0.7× 517 2.0× 132 0.7× 177 1.6× 17 1.2k
George Zarkavelis Greece 15 458 0.9× 170 0.4× 169 0.7× 158 0.8× 94 0.8× 52 813
G. Schubert-Fritschle Germany 16 485 0.9× 217 0.5× 164 0.6× 185 1.0× 59 0.5× 58 847
James L. Freddo United States 13 397 0.8× 568 1.2× 563 2.2× 294 1.5× 78 0.7× 27 1.2k
Alessandra Ravaioli Italy 19 913 1.7× 533 1.1× 210 0.8× 209 1.1× 31 0.3× 107 1.3k
Eduard Vrdoljak Croatia 15 435 0.8× 617 1.3× 465 1.8× 308 1.6× 136 1.2× 78 1.2k
Melanie Mackean United Kingdom 20 873 1.7× 469 1.0× 563 2.2× 301 1.6× 167 1.5× 48 1.7k
R. Largillier France 14 940 1.8× 334 0.7× 162 0.6× 527 2.7× 105 0.9× 47 1.5k

Countries citing papers authored by Luís Más

Since Specialization
Citations

This map shows the geographic impact of Luís Más's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Más with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Más more than expected).

Fields of papers citing papers by Luís Más

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Más. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Más. The network helps show where Luís Más may publish in the future.

Co-authorship network of co-authors of Luís Más

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Más. A scholar is included among the top collaborators of Luís Más based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Más. Luís Más is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruiz, Rossana, Claudio Flores, Natalia Valdiviezo, et al.. (2024). Clinical and outcome patterns in epithelial ovarian cancer (EOC) within a Latin American cohort.. Journal of Clinical Oncology. 42(16_suppl). e23308–e23308. 1 indexed citations
2.
Lara‐Mejía, Luis, Andrés F. Cardona, Luís Más, et al.. (2023). Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC. Journal of Thoracic Oncology. 19(1). 119–129. 11 indexed citations
3.
Zavala, Valentina A., Sandro Casavilca‐Zambrano, Carlos A. Castañeda, et al.. (2023). Breast cancer subtype and clinical characteristics in women from Peru. Frontiers in Oncology. 13. 938042–938042. 3 indexed citations
4.
5.
Más, Luís, Andrés F. Cardona, Luis Lara‐Mejía, et al.. (2022). A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population. Lung Cancer. 174. 133–140. 11 indexed citations
6.
Ruiz, Rossana, Jhajaira M. Araujo, José Manuel Gutiérrez, et al.. (2021). P09.24 Real-World Data in Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors in a Latin American Institution. Journal of Thoracic Oncology. 16(3). S300–S300. 1 indexed citations
7.
Ruiz, Rossana, et al.. (2020). Epidemiology of thymic epithelial tumors: 22‐years experience from a single‐institution. Thoracic Cancer. 12(4). 420–425. 4 indexed citations
8.
Ruiz, Rossana, Ebert Poquioma, Mivael Olivera, et al.. (2020). Lung Cancer in Peru. Journal of Thoracic Oncology. 15(6). 891–898. 6 indexed citations
9.
Ruiz, Rossana, et al.. (2019). P2.05 Real World Data on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Use in Advanced Non-small Cell Lung Cancer from a Latin American Cohort. Journal of Thoracic Oncology. 14(11). S1187–S1187. 1 indexed citations
10.
Ruiz, Rossana, et al.. (2019). P2.16-25 Epidemiology of Advanced Lung Cancer in Peru. Journal of Thoracic Oncology. 14(10). S875–S875. 2 indexed citations
11.
Raez, Luis E., R Caiña Ruiz, Brian Hunis, et al.. (2019). P2.21 Clinical Responses and Survival in Hispanic Patients vs Non-Hispanic White Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy. Journal of Thoracic Oncology. 14(11). S1193–S1194.
12.
Barrón, Feliciano, Andrés F. Cardona, Alejandro Ruíz-Patiño, et al.. (2019). PD1.05 Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced Non-small-cell Lung Cancer (CLICAP-ABs). Journal of Thoracic Oncology. 14(11). S1168–S1168. 2 indexed citations
13.
Raez, Luis E., Rossana Ruiz, Teresita Muñoz-Antonia, et al.. (2018). PS4 Clinical Outcomes in Hispanic Patients Treated with Checkpoint Inhibitors. Journal of Thoracic Oncology. 13(9). S153–S153.
14.
Pinto, Joseph A., Carlos Vallejos, Luis E. Raez, et al.. (2018). Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?. ESMO Open. 3(3). e000344–e000344. 123 indexed citations
15.
Raez, Luis E., Andrés F. Cardona, Edgardo S. Santos, et al.. (2018). The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments. Lung Cancer. 119. 7–13. 48 indexed citations
16.
Enríquez, Daniel, et al.. (2017). New Prognostic Classification for Adult T Cell Lymphoma/Leukemia Based on Hypercalcemia and Neutrophil-to-Lymphocyte Ratio. Blood. 130. 4164–4164. 1 indexed citations
17.
Corrales, Luis, Óscar Arrieta, Luís Más, et al.. (2017). An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP). Lung Cancer. 113. 30–36. 25 indexed citations
18.
Pinto, Joseph A., Christian Rolfo, Luis E. Raez, et al.. (2017). In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies. Scientific Reports. 7(1). 1526–1526. 58 indexed citations
19.
Arrieta, Óscar, Andrés F. Cardona, Claudio Martín, et al.. (2015). Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP). Journal of Thoracic Oncology. 10(5). 838–843. 143 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aránzazu Manzano Breakdown of academic impact, for papers by Catherine Shannon Breakdown of academic impact, for papers by Susan Schumer Breakdown of academic impact, for papers by George Zarkavelis Breakdown of academic impact, for papers by G. Schubert-Fritschle Breakdown of academic impact, for papers by James L. Freddo Breakdown of academic impact, for papers by Alessandra Ravaioli Breakdown of academic impact, for papers by Eduard Vrdoljak Breakdown of academic impact, for papers by Melanie Mackean Breakdown of academic impact, for papers by R. Largillier
Rankless by CCL
2026